Date(s) - September 16,2022 - September 18,2022
8:00 am - 1:00 pm
Bally's Las Vegas
HOTEL INFO: please call us to assist with room reservation
Bally’s Las Vegas
Dr. Joshua Neumiller, Pharm D., CDE, CGP, FASCP
Washington State University
Joshua Neumiller received his doctor of pharmacy degree from Washington State University in 2005, where he is currently an assistant professor in the Department of Pharmacotherapy and a member of WSU Geriatrics Team and the WSU Clinical Trials Research Team. Dr. Neumiller is a Certified Diabetes Educator (CDE), a Certified Geriatric Pharmacist (CGP), and is a Fellow of the American Society of Consultant Pharmacists. Dr. Neumiller has published on a variety of practice and research-based topics, and is a contributing author for the ADA journal Diabetes Spectrum, and is the lead pharmacist CE reviewer for the American Association of Diabetes Educators. Clinically, Dr. Neumiller is a consultant pharmacist at Elder Services, a division of Spokane Mental Health, where he provides in-home consulting services. He also serves as an investigator on multiple investigator-initiated and large multi-site clinical trials involving the study of diabetes and its complications.
Saturday September 17, 2022
RISKY DRUGS IN THE ELDERLY: RISKS OF AGING AND POLYPHARMACY
1. State clinical situations where a discontinuation or reduction of therapy may increase patient safety.
2. Develop an appropriate plan to recommend discontinuation or reduction in therapy.
3. Appreciate that established clinical criteria and expert opinion are insufficient to accurately use as stand-alone measures of prescribing quality.
4. Recognize that “polyprescriptions” are strongly associated with increased exposure of older adults to drug-drug interactions and potentially inappropriate medications.
5. Identify OTC agents that may increase the risk of falls.
6. List pharmaceutical risk reduction strategies for medication related falls.
7. Describe non-pharmaceutical risk reduction strategies for medication related falls